Selection of optimal combinations of target genes for therapeutic multi-gene silencing based on miRNA co-regulation.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 5, p. 326, doi. 10.1038/cgt.2013.20
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2013 AND VI 20 AND IP 5
Results: 8
1
2
Combined pl9Arf and interferon-beta gene transfer enhances cell death of B16 melanoma in vitro and in vivo.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 5, p. 317, doi. 10.1038/cgt.2013.23
- By:
- Publication type:
- Article
3
The use of hypoxic cultured mesenchymal stem cell for oncolytic virus therapy.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 5, p. 308, doi. 10.1038/cgt.2013.22
- By:
- Publication type:
- Article
4
Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 5, p. 298, doi. 10.1038/cgt.2013.21
- By:
- Publication type:
- Article
5
Ultrasound-targeted HSVtk and Timp³ gene delivery for synergistically enhanced antitumor effects in hepatoma.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 5, p. 290, doi. 10.1038/cgt.2013.19
- By:
- Publication type:
- Article
6
Oncolytic bovine herpesvirus type 1 infects and kills breast tumor cells and breast cancer-initiating cells irrespective of tumor subtype.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 5, p. 282, doi. 10.1038/cgt.2013.18
- By:
- Publication type:
- Article
7
Expression of β-glucuronidase on the surface of bacteria enhances activation of glucuronide prodrugs.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 5, p. 276, doi. 10.1038/cgt.2013.17
- By:
- Publication type:
- Article
8
Redifferentiation and induction of tumor suppressors miR-122 and miR-375 by the PAX8/PPARγ fusion protein inhibits anaplastic thyroid cancer: a novel therapeutic strategy.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 5, p. 267, doi. 10.1038/cgt.2013.16
- By:
- Publication type:
- Article